Advances in the role of epigenetics in homocysteine-related diseases

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet 345(9176), 407–413 (1999).
  Google Scholar
• 2. Lonn E, Yusuf S, Arnold MJ et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 354(15), 1567–1577 (2006).
  Medline CASGoogle Scholar
• 3. Koklesova L, Mazurakova A, Samec M et al. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person. EPMA J. 12(4), 477–505 (2021).
  MedlineGoogle Scholar
• 4. Motulsky AG. Nutritional ecogenetics: homocysteine-related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am. J. Hum. Genet. 58(1), 17–20 (1996).
  Medline CASGoogle Scholar
• 5. Lin C, Chen Y, Leu H et al. Anti-inflammatory strategies for homocysteine-related cardiovascular disease. Front. Biosci. 14(10), 3836–3845 (2009).
  CASGoogle Scholar
• 6. Ye Z, Wang C, Zhang Q et al. Prevalence of homocysteine-related hypertension in patients with chronic kidney disease. J. Clin. Hypertens. 19(2), 151–160 (2017).
  Medline CASGoogle Scholar
• 7. Vance SH, Tucci M, Benghuzzi H. Pathophysiological response of rhesus monkey kidney epithelial cells exposed to epigallocatechin-3-gallate. Biomed. Sci. Instrum. 41, 223–228 (2005).
  Medline CASGoogle Scholar
• 8. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am. J. Pathol. 56(1), 111–128 (1969). •• An early article that found that homocysteinemia (HHcy) can induce disease. The authors concluded that HHcy can induce arteriosclerosis in children.
  Medline CASGoogle Scholar
• 9. Nygård O, Vollset SE, Refsum H et al. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 274(19), 1526–1533 (1995).
  Medline CASGoogle Scholar
• 10. Refsum H, Ueland PM, Nygård O, Vollset SE. Homocysteine and cardiovascular disease. Annu. Rev. Med. 49, 31–62 (1998).
  Medline CASGoogle Scholar
• 11. Lonn E, Yusuf S, Arnold MJ et al. Homocysteine lowering with folic acid and B vitamins in vascular disease. N. Engl. J. Med. 354(15), 1567–1577 (2006). • Interesting article that discusses folic acid supplementation lowering Hcy without reducing the end point event.
  Medline CASGoogle Scholar
• 12. Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group, Armitage JM, Bowman L, Clarke RJ et al. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial. JAMA 303(24), 2486–2494 (2010). • Interesting article that tells the story of folic acid supplementation lowering Hcy without reducing the end point event.
  MedlineGoogle Scholar
• 13. Chan S, Hung C, Shih J et al. Exercise intervention attenuates hyperhomocystei nemia-induced aortic endothelial oxidative injury by regulating SIRT1 through mitigating NADPH oxidase/LOX-1 signaling. Redox. Biol. 14, 116–125 (2018).
  Medline CASGoogle Scholar
• 14. Chen J, Huang Y, Hu X, Bian X, Nian S. Gastrodin prevents homocysteine-induced human umbilical vein endothelial cells injury via PI3K/Akt/eNOS and Nrf2/ARE pathway. J. Cell. Mol. Med. 25(1), 345–357 (2021).
  Medline CASGoogle Scholar
• 15. Liu S, Tao J, Duan F, Li H, Tan H. HHcy induces pyroptosis and atherosclerosis via the lipid raft-mediated NOX-ROS-NLRP3 inflammasome pathway in apoE^-/- mice. Cells 11(15), 2438 (2022).
  Medline CASGoogle Scholar
• 16. Seaks CE, Weekman EM, Sudduth TL et al. Apolipoprotein E ε4/4 genotype limits response to dietary induction of hyperhomocysteinemia and resulting inflammatory signaling. J. Cereb. Blood Flow Metab. 42(5), 771–787 (2022).
  Medline CASGoogle Scholar
• 17. Ji X, Yu H, Zhou G et al. Physcion, a tetra-substituted 9,10-anthraquinone, prevents homocysteine-induced endothelial dysfunction by activating Ca²⁺- and Akt-eNOS-NO signaling pathways. Phytomedicine 81, 153410 (2021).
  Medline CASGoogle Scholar
• 18. Carluccio MA, Ancora MA, Massaro M et al. Homocysteine induces VCAM-1 gene expression through NF-kappaB and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants. Am. J. Physiol. Heart Circ. Physiol. 293(4), H2344–2354 (2007).
  Medline CASGoogle Scholar
• 19. Ji C, Yi H, Huang J, Zhang W, Zheng M. Propofol alleviates inflammation and apoptosis in HCY-induced HUVECs by inhibiting endoplasmic reticulum stress. Mol. Med. Rep. 23(5), 333 (2021).
  Medline CASGoogle Scholar
• 20. Hu H, Wang C, Jin Y et al. Catalpol inhibits homocysteine-induced oxidation and inflammation via inhibiting Nox4/NF-κB and GRP78/PERK pathways in human aorta endothelial cells. Inflammation 42(1), 64–80 (2019).
  MedlineGoogle Scholar
• 21. Zhan B, Xu Z, Zhang Y et al. Nicorandil reversed homocysteine-induced coronary microvascular dysfunction via regulating PI3K/Akt/eNOS pathway. Biomed. Pharmacother. 127, 110121 (2020).
  Medline CASGoogle Scholar
• 22. Xie X, Zhang Z, Wang X et al. Stachydrine protects eNOS uncoupling and ameliorates endothelial dysfunction induced by homocysteine. Mol. Med. 24(1), 10 (2018).
  MedlineGoogle Scholar
• 23. Jiang X, Yang F, Tan H et al. Hyperhomocystinemia impairs endothelial function and eNOS activity via PKC activation. Arterioscler. Thromb. Vasc. Biol. 25(12), 2515–2521 (2005).
  Medline CASGoogle Scholar
• 24. Wu B, Yue H, Zhou G et al. Protective effects of oxymatrine on homocystein-induced endothelial injury: involvement of mitochondria-dependent apoptosis and Akt-eNOS-NO signaling pathways. Eur. J. Pharmacol. 864, 172717 (2019).
  Medline CASGoogle Scholar
• 25. Liu Y, Zhou G, Song X et al. Emodin protects against homocysteine-induced cardiac dysfunction by inhibiting oxidative stress via MAPK and Akt/eNOS/NO signaling pathways. Eur. J. Pharmacol. 940, 175452 (2023).
  Medline CASGoogle Scholar
• 26. Flannigan KL, Agbor TA, Blackler RW et al. Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis. Proc. Natl Acad. Sci. USA 111(37), 13559–13564 (2014).
  Medline CASGoogle Scholar
• 27. Wang Y, Shi S, Dong S et al. Sodium hydrosulfide attenuates hyperhomocysteinemia rat myocardial injury through cardiac mitochondrial protection. Mol. Cell. Biochem. 399(1–2), 189–200 (2015).
  Medline CASGoogle Scholar
• 28. Zhao Z, Liu X, Shi S et al. Exogenous hydrogen sulfide protects from endothelial cell damage, platelet activation, and neutrophils extracellular traps formation in hyperhomocysteinemia rats. Exp. Cell Res. 370(2), 434–443 (2018).
  Medline CASGoogle Scholar
• 29. Nakladal D, Lambooy SPH, Mišúth S et al. Homozygous whole body Cbs knockout in adult mice features minimal pathology during ageing despite severe homocysteinemia. FASEB J. 36(4), e22260 (2022).
  Medline CASGoogle Scholar
• 30. Han L, Miao Y, Zhao Y et al. The binding of autotaxin to integrins mediates hyperhomocysteinemia-potentiated platelet activation and thrombosis in mice and humans. Blood Adv. 6(1), 46–61 (2022).
  Medline CASGoogle Scholar
• 31. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler. Thromb. 13(9), 1327–1333 (1993).
  Medline CASGoogle Scholar
• 32. Kolodziejczyk-Czepas J, Talar B, Nowak P, Olas B, Wachowicz B. Homocysteine and its thiolactone impair plasmin activity induced by urokinase or streptokinase in vitro. Int. J. Biol. Macromol. 50(3), 754–758 (2012).
  Medline CASGoogle Scholar
• 33. Malinowska J, Tomczynska M, Olas B. Changes of blood platelet adhesion to collagen and fibrinogen induced by homocysteine and its thiolactone. Clin. Biochem. 45(15), 1225–1228 (2012).
  Medline CASGoogle Scholar
• 34. Sauls DL, Wolberg AS, Hoffman M. Elevated plasma homocysteine leads to alterations in fibrin clot structure and stability: implications for the mechanism of thrombosis in hyperhomocysteinemia. J. Thromb. Haemost. 1(2), 300–306 (2003).
  Medline CASGoogle Scholar
• 35. Siennicka A, Zuchowski M, Chełstowski K, Cnotliwy M, Clark JS, Jastrzębska M. Homocysteine-enhanced proteolytic and fibrinolytic processes in thin intraluminal thrombus and adjacent wall of abdominal aortic aneurysm: study in vitro. Biomed Res. Int. 2018, 3205324 (2018).
  MedlineGoogle Scholar
• 36. Bao XM, Zheng H. Atorvastatin attenuates homocysteine-induced migration of smooth muscle cells through mevalonate pathway involving reactive oxygen species and p38 MAPK. Clin. Exp. Pharmacol. Physiol. 42( 8), 865–873 (2015).
  MedlineGoogle Scholar
• 37. Liu J, Yan X, Wang Z, Zhang N, Lin A, Li Z. Adipocyte factor CTRP6 inhibits homocysteine-induced proliferation, migration, and dedifferentiation of vascular smooth muscle cells through PPARγ/NLRP3. Biochem. Cell Biol. 99(5), 596–605 (2021).
  Medline CASGoogle Scholar
• 38. Ji J, Feng M, Niu X, Zhang X, Wang Y. Liraglutide blocks the proliferation, migration and phenotypic switching of homocysteine (Hcy)-induced vascular smooth muscle cells (VSMCs) by suppressing proprotein convertase subtilisin kexin9 (PCSK9)/low-density lipoprotein receptor (LDLR). Bioengineered 12(1), 8057–8066 (2021).
  Medline CASGoogle Scholar
• 39. Ma H, Wang L, Lv W, Lv Z. Effects of miR-7 on Hcy-induced rat cerebral arterial vascular smooth muscle cell proliferation, migration and inflammatory factor expression by targeting MMP-14 to regulate TLR4/NF-κB signaling pathway. Cell. Mol. Biol. (Noisy-le-grand) 66(7), 12–17 (2020).
  MedlineGoogle Scholar
• 40. Duan H, Li Y, Yan L et al. MicroRNA-217 suppresses homocysteine-induced proliferation and migration of vascular smooth muscle cells via N-methyl-D-aspartic acid receptor inhibition. Clin. Exp. Pharmacol. Physiol. 43(10), 967–975 (2016).
  Medline CASGoogle Scholar
• 41. Meng L, Liu L, Zhou C et al. Polyphenols and polypeptides in Chinese rice wine inhibit homocysteine-induced proliferation and migration of vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 67(6), 482–490 (2016).
  Medline CASGoogle Scholar
• 42. Luo X, Xiao Y, Song F, Yang Y, Xia M, Ling W. Increased plasma S-adenosyl-homocysteine levels induce the proliferation and migration of VSMCs through an oxidative stress-ERK1/2 pathway in apoE(-/-) mice. Cardiovasc. Res. 95(2), 241–250 (2012).
  Medline CASGoogle Scholar
• 43. Chou Y, Lin H, Chen K, Chang C, Lee W, Juan S. Molecular mechanisms underlying the anti-proliferative and anti-migratory effects of folate on homocysteine-challenged rat aortic smooth muscle cells. Br. J. Pharmacol. 169(7), 1447–1460 (2013).
  Medline CASGoogle Scholar
• 44. Zhang T, Lu R, Chen Y et al. Hyperhomocysteinemia and dyslipidemia in point mutation G307S of cystathionine β-synthase-deficient rabbit generated using CRISPR/Cas9. Lipids Health Dis. 19(1), 224 (2020).
  Medline CASGoogle Scholar
• 45. Minno AD, Anesi A, Chiesa M et al. Plasma phospholipid dysregulation in patients with cystathionine-β synthase deficiency. Nutr. Metab. Cardiovasc. Dis. 30(12), 2286–2295 (2020).
  MedlineGoogle Scholar
• 46. Al-Shabrawey M, Elmarakby A, Samra Y et al. Hyperhomocysteinemia dysregulates plasma levels of polyunsaturated fatty acids-derived eicosanoids. Life Res. (Auckl.) 5(2), 14 (2022).
  MedlineGoogle Scholar
• 47. Werstuck GH, Lentz SR, Dayal S et al. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Investig. 107(10), 1263–1273 (2001).
  Medline CASGoogle Scholar
• 48. Mikael EG, Genest J, Rozen R. Elevated homocysteine reduces apolipoprotein A-I expression in hyperhomocysteinemic mice and in males with coronary artery disease. Circ. Res. 98(4), 564–571 (2006).
  Medline CASGoogle Scholar
• 49. Liao D, Tan H, Hui R et al. Hyperhomocysteinemia decreases circulating high-density lipoprotein by inhibiting apolipoprotein A-I protein synthesis and enhancing HDL cholesterol clearance. Circ. Res. 99(6), 598–606 (2006).
  Medline CASGoogle Scholar
• 50. Van der PA, Van Gilst WH, Voors AA et al. Treating oxidative stress in heart failure: past, present and future. Eur. J. Heart Fail. 21(4), 425–435 (2019).
  MedlineGoogle Scholar
• 51. Liguori I, Russo G, Curcio F et al. Oxidative stress, aging, and diseases. Clin. Interv. Aging 13, 757–772 (2018).
  Medline CASGoogle Scholar
• 52. Richard E, Gallego-Villar L, Rivera-Barahona A et al. Altered redox homeostasis in branched-chain amino acid disorders, organic acidurias, and homocystinuria. Oxid. Med. Cell. Longev. 2018, 1246069 (2018).
  MedlineGoogle Scholar
• 53. Ji X, YU H, Zhou G et al. Physcion, a tetra-substituted 9,10-anthraquinone, prevents homocysteine-induced endothelial dysfunction by activating Ca²⁺- and Akt-eNOS-NO signaling pathways. Phytomedicine 81, 153410 (2021).
  Medline CASGoogle Scholar
• 54. Esse R, Barroso M, de-Almeida IT, Castro R. The contribution of homocysteine metabolism disruption to endothelial dysfunction: state-of-the-art. Int. J. Mol. Sci. 20(4), 867 (2019).
  Medline CASGoogle Scholar
• 55. Lai W, Kan M. Homocysteine-induced endothelial dysfunction. Ann. Nutr. Metab. 67(1), 1–12 (2015).
  Medline CASGoogle Scholar
• 56. Suvorava T, Metry S, Pick S, Kojda G. Alterations in endothelial nitric oxide synthase activity and their relevance to blood pressure. Biochem. Pharmacol. 205, 115256 (2022).
  Medline CASGoogle Scholar
• 57. Singh J, Lee Y, Kellum JA. A new perspective on NO pathway in sepsis and ADMA lowering as a potential therapeutic approach. Crit. Care 26(1), 246 (2022).
  MedlineGoogle Scholar
• 58. Işıklar OO, Barutcuoğlu B, Kabaroğlu C et al. Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases? Clin. Biochem. 45(16–17), 1325–1330 (2012).
  Medline CASGoogle Scholar
• 59. Zhang J, Liu J, Li Z, Wang L, Jiang Y, Wang S. Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene. Chin. Med. J. 120(23), 2132–2137 (2007).
  Medline CASGoogle Scholar
• 60. Zhao Z, Liu X, Shi S et al. Exogenous hydrogen sulfide protects from endothelial cell damage, platelet activation, and neutrophils extracellular traps formation in hyperhomocysteinemia rats. Exp. Cell Res. 370(2), 434–443 (2018).
  Medline CASGoogle Scholar
• 61. Kumar M, Sandhir R. Hydrogen sulfide attenuates hyperhomocysteinemia-induced blood-brain barrier permeability by inhibiting MMP-9. Int. J. Neurosci. 132(11), 1061–1071 (2022).
  Medline CASGoogle Scholar
• 62. Han L, Miao Y, Zhao Y et al. The binding of autotaxin to integrins mediates hyperhomocysteinemia-potentiated platelet activation and thrombosis in mice and humans. Blood Adv. 6(1), 46–61 (2022).
  Medline CASGoogle Scholar
• 63. Tsai JC, Wang H, Perrella MA et al. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J. Clin. Investig. 97(1), 146–153 (1996).
  Medline CASGoogle Scholar
• 64. Han X, Zhang H, Cao C et al. Aberrant DNA methylation of the PDGF gene in homocysteinemediated VSMC proliferation and its underlying mechanism. Mol. Med. Rep. 10(2), 947–954 (2014).
  Medline CASGoogle Scholar
• 65. Xu L, Hao H, Hao Y et al. Aberrant MFN2 transcription facilitates homocysteine-induced VSMCs proliferation via the increased binding of c-Myc to DNMT1 in atherosclerosis. J. Cell. Mol. Med. 23(7), 4611–4626 (2019).
  Medline CASGoogle Scholar
• 66. Blachier F, Andriamihaja M, Blais A. Sulfur-containing amino acids and lipid metabolism. J. Nutr. 150(Suppl. 1), S2524–S2531 (2020).
  Google Scholar
• 67. Visram M, Radulovic M, Steiner S et al. Homocysteine regulates fatty acid and lipid metabolism in yeast. J. Biol. Chem. 293(15), 5544–5555 (2018).
  Medline CASGoogle Scholar
• 68. Wang X, Zhang Y, Ma H. Targeted profiling of amino acid metabolome in serum by a liquid chromatography–mass spectrometry method: application to identify potential markers for diet-induced hyperlipidemia. Anal. Methods 12(18), 2355–2362 (2020).
  Medline CASGoogle Scholar
• 69. Velez-Carrasco W, Merkel M, Twiss CO, Smith JD. Dietary methionine effects on plasma homocysteine and HDL metabolism in mice. J. Nutr. Biochem. 19(6), 362–370 (2008).
  Medline CASGoogle Scholar
• 70. Liu Y, Tian T, Zhang H, Gao L, Zhou X. The effect of homocystein-lowering therapy with folic acid on flow-mediated vasodilation in patients with coronary artery disease: a meta-analysis of randomized controlled trials. Atherosclerosis 235(1), 31–35 (2014).
  Medline CASGoogle Scholar
• 71. Li Y. Modern epigenetics methods in biological research. Methods 187, 104–113 (2021).
  Medline CASGoogle Scholar
• 72. Mattei AL, Bailly N, Meissner A. DNA methylation: a historical perspective. Trends Genet. 38(7), 676–707 (2022).
  Medline CASGoogle Scholar
• 73. Ram O, Goren A, Amit I et al. Combinatorial patterning of chromatin regulators uncovered by genome-wide location analysis in human cells. Cell 147, 1628–1639 (2011).
  Medline CASGoogle Scholar
• 74. Yun J, Jialal I, Devaraj S. Epigenetic regulation of high glucoseinduced proinflammatory cytokine production in monocytes by curcumin. J. Nutr. Biochem. 22(5), 450–458 (2011).
  Medline CASGoogle Scholar
• 75. Reddy MA, Natarajan R. Epigenetic mechanisms in diabetic vascular complications. Cardiovasc. Res. 90(3), 421–429 (2011).
  Medline CASGoogle Scholar
• 76. Dozmorov MG, Giles CB, Koelsch KA, Wren JD. Systematic classification of non-coding RNAs by epigenomic similarity. BMC Bioinform. 14(Suppl. 14), S2 (2013).
  MedlineGoogle Scholar
• 77. Chen L, Heikkinen L, Wang C, Yang Y, Sun H, Wong G. Trends in the development of miRNA bioinformatics tools. Brief. Bioinformatics 20(5), 1836–1852 (2019).
  Medline CASGoogle Scholar
• 78. Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J. Cell Biol. 220(2), e202009045 (2021).
  Medline CASGoogle Scholar
• 79. Chen L, Wang C, Sun H et al. The bioinformatics toolbox for circRNA discovery and analysis. Brief. Bioinformatics 22(2), 1706–1728 (2021).
  Medline CASGoogle Scholar
• 80. Rafnar T, Sulem P, Thorleifsson G et al. Genome-wide association study yields variants at 20p12.2 that associate with urinary bladder cancer. Hum. Mol. Genet. 23(20), 5545–5557 (2014).
  Medline CASGoogle Scholar
• 81. Heshmatzad K, Naderi N, Maleki M et al. Role of non-coding variants in cardiovascular disease. J. Cell. Mol. Med. 27(12), 1621–1636 (2023).
  Medline CASGoogle Scholar
• 82. Dong S, Zhang Y, Chen Y et al. Comprehensive review and annotation of susceptibility SNPs associated with obesity-related traits. Obes. Rev. 19(7), 917–930 (2018).
  Medline CASGoogle Scholar
• 83. Rojano E, Ranea JA, Perkins JR. Characterisation of non-coding genetic variation in histamine receptors using AnNCR-SNP. Amino Acids 48(10), 2433–2442 (2016).
  Medline CASGoogle Scholar
• 84. Gate RE, Cheng CS, Aiden AP et al. Genetic determinants of co-accessible chromatin regions in activated T cells across humans. Nat. Genet. 50(8), 1140–1150 (2018).
  Medline CASGoogle Scholar
• 85. Loscalzo J, Handy DE. Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series). Pulm. Circ. 4(2), 169–174 (2014).
  MedlineGoogle Scholar
• 86. Pogribny IP, Karpf AR, James SR, Melnyk S, Han T, Tryndyak VP. Epigenetic alterations in the brains of Fisher 344 rats induced by long-term administration of folate/methyl-deficient diet. Brain Res. 1237, 25–34 (2008). • It is widely believed that homocysteine induces the reduction of the SAM/SAH ratio, which in turn induces DNA hypomethylation and promotes the occurrence of the disease. However, this article shows that this is not absolute and the association between SAM/SAH and gene-specific DNA methylation is tissue-specific.
  Medline CASGoogle Scholar
• 87. Glier MB, Ngai YF, Sulistyoningrum DC, Aleliunas RE, Bottiglieri T, Devlin AM. Tissue-specific relationship of s-adenosylhomocysteine with allele-specific H19/IGF2 methylation and imprinting in mice with hyperhomocysteinemia. Epigenetics 8(1), 44–53 (2013).
  Medline CASGoogle Scholar
• 88. Esse R, Imbard A, Florindo C et al. Protein arginine hypomethylation in a mouse model of cystathionine beta-synthase deficiency. FASEB J. 28(6), 2686–2695 (2014).
  Medline CASGoogle Scholar
• 89. Lee H, Wang L, Kuo Y et al. Lack of global epigenetic methylation defects in CBS deficient mice. J. Inherit. Metab. Dis. 40(1), 113–120 (2017).
  Medline CASGoogle Scholar
• 90. Fu Y, Wang X, Kong W. Hyperhomocysteinaemia and vascular injury: advances in mechanisms and drug targets. Br. J. Pharmacol. 175(8), 1173–1189 (2018).
  Medline CASGoogle Scholar
• 91. Wang W, Jin H. Homocysteine: a potential common route for cardiovascular risk and DNA methylation in psoriasis. Chin. Med. J. 130(16), 1980–1986 (2017).
  Medline CASGoogle Scholar
• 92. Schumann NAB, Mendonça AS, Silveira MM et al. Procaine and S-adenosyl-l-homocysteine affect the expression of genes related to the epigenetic machinery and change the DNA methylation status of in vitro cultured bovine skin fibroblasts. DNA Cell Biol. 39(1), 37–49 (2020).
  Medline CASGoogle Scholar
• 93. Zhang D, Chen Y, Xie X et al. Homocysteine activates vascular smooth muscle cells by DNA demethylation of platelet-derived growth factor in endothelial cells. J. Mol. Cell. Cardiol. 53(4), 487–496 (2012).
  MedlineGoogle Scholar
• 94. Jiang Y, Jiang J, Xiong J et al. Homocysteine-induced extracellular superoxide dismutase and its epigenetic mechanisms in monocytes. J. Exp. Biol. 211(Pt 6), 911–920 (2008).
  Medline CASGoogle Scholar
• 95. Li J, Barrero C, Gupta S, Kruger WD, Merali S, Praticò D. Homocysteine modulates 5-lipoxygenase expression level via DNA methylation. Aging Cell 16(2), 273–280 (2017).
  Medline CASGoogle Scholar
• 96. Ma S, Hao Y, Jiao Y et al. Homocysteine-induced oxidative stress througH TLR4/NF-ΚB/DNMT1-mediated LOX-1 DNA methylation in endothelial cells. Mol. Med. Rep. 16(6), 9181–9188 (2017).
  Medline CASGoogle Scholar
• 97. Wu H, Li Z, Yang Y et al. Rap1A accelerates homocysteine-induced ANA-1 cells inflammation via synergy of FoxO1 and DNMT3a. Cell. Signal. 106, 110627 (2023).
  Medline CASGoogle Scholar
• 98. Xu L, Hao H, Hao Y et al. Aberrant MFN2 transcription facilitates homocysteine-induced VSMCs proliferation via the increased binding of c-Myc to DNMT1 in atherosclerosis. J. Cell. Mol. Med. 23(7), 4611–4626 (2019).
  Medline CASGoogle Scholar
• 99. Guo W, Zhang H, Yang A et al. Homocysteine accelerates atherosclerosis by inhibiting scavenger receptor class B member1 via DNMT3b/SP1 pathway. J. Mol. Cell. Cardiol. 138, 34–48 (2020).
  Medline CASGoogle Scholar
• 100. Wang H, Yoshizumi M, Lai K et al. Inhibition of growth and p21RAS methylation in vascular endothelial cells by homocysteine but not cysteine. J. Biol. Chem. 272(40), 25380–25385 (1997).
  Medline CASGoogle Scholar
• 101. Gou Y, Ye Q, Liang X et al. Homocysteine restrains hippocampal neurogenesis in focal ischemic rat brain by inhibiting DNA methylation. Neurochem. Int. 147, 105065 (2021).
  Medline CASGoogle Scholar
• 102. Yang Z, Wang L, Zhang W, Wang X, Zhou S. Plasma homocysteine involved in methylation and expression of thrombomodulin in cerebral infarction. Biochem. Biophys. Res. Commun. 473(4), 1218–1222 (2016).
  Medline CASGoogle Scholar
• 103. Pushpakumar S, Kundu S, Narayanan N, Sen U. DNA hypermethylation in hyperhomocysteinemia contributes to abnormal extracellular matrix metabolism in the kidney. FASEB J. 29(11), 4713–4725 (2015).
  Medline CASGoogle Scholar
• 104. Ding N, Xie L, Ma F et al. miR-30a-5p promotes glomerular podocyte apoptosis via DNMT1-mediated hypermethylation under hyperhomocysteinemia. Acta. Biochim. Biophys. Sin. 54(1), 126–136 (2022).
  CASGoogle Scholar
• 105. Xie L, Ma S, Ding N et al. Homocysteine induces podocyte apoptosis by regulating miR-1929-5p expression through c-Myc, DNMT1 and EZH2. Mol. Oncol. 15(11), 3203–3221 (2021).
  Medline CASGoogle Scholar
• 106. Scarpa S, Fuso A, D’Anselmi F, Cavallaro RA. Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? FEBS Lett. 541(1–3), 145–148 (2003).
  Medline CASGoogle Scholar
• 107. Pi T, Lang G, Liu B, Shi J. Protective effects of Dendrobium nobile Lindl. alkaloids on Alzheimer’s disease-like symptoms induced by high-methionine diet. Curr. Neuropharmacol. 20(5), 983–997 (2022).
  Medline CASGoogle Scholar
• 108. Zeng P, Shi Y, Wang X et al. Emodin rescued hyperhomocysteinemia-induced dementia and Alzheimer’s disease-like features in rats. Int. J. Neuropsychopharmacol. 22(1), 57–70 (2019).
  Medline CASGoogle Scholar
• 109. Wang S, Wang X, Zhao Y et al. Homocysteine-induced disturbances in DNA methylation contribute to development of stress-associated cognitive decline in rats. Neurosci. Bull. 38(8), 887–900 (2022).
  Medline CASGoogle Scholar
• 110. Shen J, Jiao Y, Ding N et al. Homocysteine facilitates endoplasmic reticulum stress and apoptosis of hepatocytes by suppressing ERO1α expression via cooperation between DNMT1 and G9a. Cell Biol. Int. 46(8), 1236–1248 (2022).
  Medline CASGoogle Scholar
• 111. Yang A, Zeng W, Zhang H et al. Homocysteine accelerates hepatocyte autophagy by upregulating TFEB via DNMT3b-mediated DNA hypomethylation. Acta Biochim. Biophys. Sin. 55(8), 1184–1192 (2023).
  Google Scholar
• 112. Kowluru RA. Diabetic retinopathy: mitochondria caught in a muddle of homocysteine. J. Clin. Med. 9(9), 3019 (2020).
  Medline CASGoogle Scholar
• 113. Mohammad G, Kowluru RA. Homocysteine disrupts balance between MMP-9 and its tissue inhibitor in diabetic retinopathy: the role of DNA methylation. Int. J. Mol. Sci. 21(5), 1771 (2020).
  Medline CASGoogle Scholar
• 114. Tao H, Shi P, Xuan H, Ding X. DNA methyltransferase-1 inactivation of androgen receptor axis triggers homocysteine induced cardiac fibroblast autophagy in diabetic cardiac fibrosis. Arch. Biochem. Biophys. 692, 108521 (2020).
  Medline CASGoogle Scholar
• 115. Zhang D, Lou J, Zhang X et al. Hyperhomocysteinemia results from and promotes hepatocellular carcinoma via CYP450 metabolism by CYP2J2 DNA methylation. Oncotarget 8(9), 15377–15392 (2017).
  MedlineGoogle Scholar
• 116. Naushad SM, Reddy CA, Kumaraswami K et al. Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective. Cell Biochem. Biophys. 68(2), 397–406 (2014).
  Medline CASGoogle Scholar
• 117. Zhang H, Wang Y, Ma S et al. Homocysteine inhibits endothelial progenitor cells proliferation via DNMT1-mediated hypomethylation of cyclin A. Exp. Cell Res. 362(1), 217–226 (2018).
  Medline CASGoogle Scholar
• 118. Xiao Y, Xia J, Cheng J et al. Inhibition of S-adenosylhomocysteine hydrolase induces endothelial dysfunction via epigenetic regulation of p66shc-mediated oxidative stress pathway. Circulation 139(19), 2260–2277 (2019).
  Medline CASGoogle Scholar
• 119. Jamaluddin MS, Yang X, Wang H. Hyperhomocysteinemia, DNA methylation and vascular disease. Clin. Chem. Lab. Med. 45(12), 1660–1666 (2007).
  Medline CASGoogle Scholar
• 120. Esse R, Teerlink T, Koolwijk P et al. Folinic acid increases protein arginine methylation in human endothelial cells. Nutrients 10(4), 404 (2018).
  MedlineGoogle Scholar
• 121. Ma S, Lu G, Zhang Q et al. Extracellular-superoxide dismutase DNA methylation promotes oxidative stress in homocysteine-induced atherosclerosis. Acta Biochim. Biophys. Sin. 54(9), 1222–1233 (2022).
  CASGoogle Scholar
• 122. Feng P, Liang Y, Lin W et al. Homocysteine induced oxidative stress in human umbilical vein endothelial cells via regulating methylation of SORBS1. Eur. Rev. Med. Pharmacol. Sci. 22(20), 6948–6958 (2018).
  MedlineGoogle Scholar
• 123. Wei L, Chao N, Gao S et al. Homocysteine induces vascular inflammatory response via SMAD7 hypermethylation in human umbilical vein smooth muscle cells. Microvasc. Res. 120, 8–12 (2018).
  Medline CASGoogle Scholar
• 124. Li L, Xie J, Zhang M, Wang S. Homocysteine harasses the imprinting expression of IGF2 and H19 by demethylation of differentially methylated region between IGF2/H19 genes. Acta Biochim. Biophys. Sin. 41(6), 464–471 (2009).
  CASGoogle Scholar
• 125. Zhang D, Wen X, Wu W, Xu E, Zhang Y, Cui W. Homocysteine-related HTERT DNA demethylation contributes to shortened leukocyte telomere length in atherosclerosis. Atherosclerosis 231(1), 173–179 (2013).
  Medline CASGoogle Scholar
• 126. Spence JD. Nutrition and risk of stroke. Nutrients 11(3), 647 (2019).
  Medline CASGoogle Scholar
• 127. Wang C, Xu G, Wen Q et al. CBS promoter hypermethylation increases the risk of hypertension and stroke. Clinics (Sao Paulo) 74, e630 (2019).
  MedlineGoogle Scholar
• 128. Zhang D, Wen X, Zhang L, Cui W. DNA methylation of human telomerase reverse transcriptase associated with leukocyte telomere length shortening in hyperhomocysteinemia-type hypertension in humans and in a rat model. Circ. J. 78(8), 1915–1923 (2014).
  Medline CASGoogle Scholar
• 129. Wan C, Zong R, Chen X. The new mechanism of cognitive decline induced by hypertension: high homocysteine-mediated aberrant DNA methylation. Front. Cardiovasc. Med. 9, 928701 (2022).
  Medline CASGoogle Scholar
• 130. Hu J, Zhu H, Xu G et al. Significant association between DHFR promoter methylation and ischemic stroke in a Chinese hypertensive population. J. Clin. Lab. Anal. 34(8), e23322 (2020).
  Medline CASGoogle Scholar
• 131. Li D, Zhao Q, Zhang C, Huang X, Godfrey O, Zhang W. Associations of MTRR A66G polymorphism and promoter methylation with ischemic stroke in patients with hyperhomocysteinemia. J. Gene Med. 22(5), e3170 (2020).
  Medline CASGoogle Scholar
• 132. Lin Y, Kong J, Tian T et al. Identification of novel phenotypes correlated with CKD: a phenotype-wide association study. Int. J. Med. Sci. 19(13), 1920–1928 (2022).
  Medline CASGoogle Scholar
• 133. Yang X, Cao R, Yu Y et al. A study on the correlation between MTHFR promoter methylation and diabetic nephropathy. Am. J. Transl. Res. 8(11), 4960–4967 (2016).
  Medline CASGoogle Scholar
• 134. Ingrosso D, Cimmino A, Perna AF et al. Folate treatment and unbalanced methylation and changes of allelic expression induced by hyperhomocysteinaemia in patients with uraemia. Lancet 361(9370), 1693–1699 (2003).
  Medline CASGoogle Scholar
• 135. Li J, Barrero C, Gupta S, Kruger WD, Merali S, Praticò D. Homocysteine modulates 5-lipoxygenase expression level via DNA methylation. Aging Cell 16(2), 273–280 (2017).
  Medline CASGoogle Scholar
• 136. Pi T, Liu B, Shi J. Abnormal homocysteine metabolism: an insight of Alzheimer’s disease from DNA methylation. Behav. Neurol. 2020, 8438602 (2020).
  MedlineGoogle Scholar
• 137. Ouyang Y, Wu Q, Li J, Sun S, Sun S. S-adenosylmethionine: a metabolite critical to the regulation of autophagy. Cell Prolif. 53(11), e12891 (2020).
  Medline CASGoogle Scholar
• 138. Kowluru RA, Mohammad G, Sahajpal N. Faulty homocysteine recycling in diabetic retinopathy. Eye Vis. (Lond). 7, 4 (2020).
  MedlineGoogle Scholar
• 139. Wu L, Wu J. Hyperhomocysteinemia is a risk factor for cancer and a new potential tumor marker. Clin. Chim. Acta 22(1–2), 21–28 (2002).
  Google Scholar
• 140. Sullivan MR, Darnell AM, Reilly MF et al. Methionine synthase is essential for cancer cell proliferation in physiological folate environments. Nat. Metab. 3(11), 1500–1511 (2021).
  Medline CASGoogle Scholar
• 141. Sedillo JC, Cryns VL. Targeting the methionine addiction of cancer. Am. J. Cancer Res. 12(5), 2249–2276 (2022).
  Medline CASGoogle Scholar
• 142. Ding W, Zhou D, Jiang X, Lu L. Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies. PLoS ONE 8(4), e60508 (2013).
  Medline CASGoogle Scholar
• 143. Vantaku V, Amara CS, Piyarathna DWB et al. DNA methylation patterns in bladder tumors of African American patients point to distinct alterations in xenobiotic metabolism. Carcinogenesis 40(11), 1332–1340 (2019).
  Medline CASGoogle Scholar
• 144. Yadav S, Longkumer I, Garg PR et al. Association of air pollution and homocysteine with global DNA methylation: a population-based study from North India. PLoS ONE 16(12), e0260860 (2021).
  Medline CASGoogle Scholar
• 145. McCaddon A, Regland B. COVID-19: a methyl-group assault? Med. Hypotheses 149, 110543 (2021).
  Medline CASGoogle Scholar
• 146. Jia L, Zeng Y, Hu Y et al. Homocysteine impairs porcine oocyte quality via deregulation of one-carbon metabolism and hypermethylation of mitochondrial DNA. Biol. Reprod. 100(4), 907–916 (2019).
  MedlineGoogle Scholar
• 147. Hoeijmakers L, Kempe H, Verschure PJ. Epigenetic imprinting during assisted reproductive technologies: the effect of temporal and cumulative fluctuations in methionine cycling on the DNA methylation state. Mol. Reprod. Dev. 83(2), 94–107 (2016).
  Medline CASGoogle Scholar
• 148. Stillman B. Histone modifications: insights into their influence on gene expression. Cell 175(1), 6–9 (2018).
  Medline CASGoogle Scholar
• 149. Demetriadou C, Koufaris C, Kirmizis A. Histone N-alpha terminal modifications: genome regulation at the tip of the tail. Epigenetics Chromatin 13(1), 29 (2020).
  Medline CASGoogle Scholar
• 150. Roth SY, Denu JM, Allis CD. Histone acetyltransferases. Annu. Rev. Biochem. 70, 81–120 (2001).
  Medline CASGoogle Scholar
• 151. Zhao Q, Li S, Li N et al. miR-34a targets HDAC1-regulated H3K9 acetylation on lipid accumulation induced by homocysteine in foam cells. J. Cell. Biochem. 118(12), 4617–4627 (2017).
  Medline CASGoogle Scholar
• 152. Xiong J, Ma F, Ding N et al. miR-195-3p alleviates homocysteine-mediated atherosclerosis by targeting IL-31 through its epigenetics modifications. Aging Cell 20(10), e13485 (2021).
  Medline CASGoogle Scholar
• 153. Qin X, Shan Y, Dou M, Li F, Guo Y. Notch1 signaling activation alleviates coronary microvascular dysfunction through histone modification of Nrg-1 via the interaction between NICD and GCN5. Apoptosis 28(1–2), 124–135 (2023).
  Medline CASGoogle Scholar
• 154. Elmasry K, Mohamed R, Sharma I et al. Epigenetic modifications in hyperhomocysteinemia: potential role in diabetic retinopathy and age-related macular degeneration. Oncotarget 9(16), 12562–12590 (2018).
  MedlineGoogle Scholar
• 155. Tóthová B, Kovalská M, Kalenská D, Tomašcová A, Lehotský J. Histone hyperacetylation as a response to global brain ischemia associated with hyperhomocysteinemia in rats. Int. J. Mol. Sci. 19(10), 3147 (2018).
  MedlineGoogle Scholar
• 156. Won SB, Han A, Kwon YH. Maternal consumption of low-isoflavone soy protein isolate alters hepatic gene expression and liver development in rat offspring. J. Nutr. Biochem. 42, 51–61 (2017).
  Medline CASGoogle Scholar
• 157. Greer EL, Shi Y. Histone methylation: a dynamic mark in health, disease and inheritance. Nat. Rev. Genet. 13(5), 343–357 (2012).
  Medline CASGoogle Scholar
• 158. Cong G, Yan R, Huang H et al. Involvement of histone methylation in macrophage apoptosis and unstable plaque formation in methionine-induced hyperhomocysteinemic ApoE^-/- mice. Life Sci. 173, 135–144 (2017).
  Medline CASGoogle Scholar
• 159. Xie L, Ding N, Zhang H et al. SNF5 promotes IL-1β expression via H3K4me1 in atherosclerosis induced by homocysteine. Int. J. Biochem. Cell Biol. 135, 105974 (2021).
  Medline CASGoogle Scholar
• 160. Whalen CA, Mattie FJ, Florindo C et al. No effect of diet-induced mild hyperhomocysteinemia on vascular methylating capacity, atherosclerosis progression, and specific histone methylation. Nutrients 12(8), 2182 (2020).
  Medline CASGoogle Scholar
• 161. Yang A, Jiao Y, Yang S et al. Homocysteine activates autophagy by inhibition of CFTR expression via interaction between DNA methylation and H3K27me3 in mouse liver. Cell Death Dis. 9(2), 169 (2018).
  MedlineGoogle Scholar
• 162. Aoki Y, Tome Y, Han Q et al. Histone H3 lysine-trimethylation markers are decreased by recombinant methioninase and increased by methotrexate at concentrations which inhibit methionine-addicted osteosarcoma cell proliferation. Biochem. Biophys. Rep. 28, 101177 (2021).
  Medline CASGoogle Scholar
• 163. Cunningham A, Erdem A, Alshamleh I et al. Dietary methionine starvation impairs acute myeloid leukemia progression. Blood 140(19), 2037–2052 (2022).
  Medline CASGoogle Scholar
• 164. Jan M, Cueto R, Jiang X et al. Molecular processes mediating hyperhomocysteinemia-induced metabolic reprogramming, redox regulation and growth inhibition in endothelial cells. Redox. Biol. 45, 102018 (2021).
  Medline CASGoogle Scholar
• 165. Qin X, Shan Y, Gao J, Li F, Guo Y. E3 ubiquitin ligase mind bomb 1 overexpression reduces apoptosis and inflammation of cardiac microvascular endothelial cells in coronary microvascular dysfunction. Cell. Signal. 91, 110223 (2022).
  Medline CASGoogle Scholar
• 166. Sun W, Wang X, Novakovic A, Wang J, He G, Yang Q. Protection of dilator function of coronary arteries from homocysteine by tetramethylpyrazine: role of ER stress in modulation of BK_Ca channels. Vascul. Pharmacol. 113, 27–37 (2019).
  Medline CASGoogle Scholar
• 167. Derouiche F, Bôle-Feysot C, Naïmi D, Coëffier M. Hyperhomocysteinemia-induced oxidative stress differentially alters proteasome composition and activities in heart and aorta. Biochem. Biophys. Res. Commun. 452(3), 740–745 (2014).
  Medline CASGoogle Scholar
• 168. Wang L, Lai G, Chu G, Liang X, Zhao Y. cMyBP-C was decreased via KLHL3-mediated proteasomal degradation in congenital heart diseases. Exp. Cell Res. 355(1), 18–25 (2017).
  MedlineGoogle Scholar
• 169. Tripathi M, Singh BK, Zhou J et al. Vitamin B₁₂ and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation. J. Hepatol. 77(5), 1246–1255 (2022).
  Medline CASGoogle Scholar
• 170. Xiang W, Yang Y, Weng L et al. Hyperhomocysteinemia activates NLRP3 inflammasome to cause hepatic steatosis and insulin resistance via MDM2-mediated ubiquitination of HSF1. Int. Immunopharmacol. 118, 110085 (2023).
  Medline CASGoogle Scholar
• 171. Tian X, Gong L, Jin A, Wang Y, Zhou X, Tan Y. E3 ubiquitin ligase SIAH-1 nuclear accumulation is critical for homocysteine induced impairment of C6 astroglioma cells. Mol. Med. Rep. 20(3), 2227–2235 (2019).
  Medline CASGoogle Scholar
• 172. Bretes E, Zimny J. Homocysteine thiolactone affects protein ubiquitination in yeast. Acta Biochim. Pol. 60(3), 485–488 (2013).
  Medline CASGoogle Scholar
• 173. Rossetto D, Avvakumov N, Côté J. Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics 7(10), 1098–1108 (2012).
  Medline CASGoogle Scholar
• 174. Lowndes NF, Toh GW. DNA repair: the importance of phosphorylating histone H2AX. Curr. Biol. 15(3), R99–R102 (2005).
  Medline CASGoogle Scholar
• 175. Palmer AM, Kamynina E, Field MS, Stover PJ. Folate rescues vitamin B₁₂ depletion-induced inhibition of nuclear thymidylate biosynthesis and genome instability. Proc. Natl Acad. Sci. USA 114(20), E4095–E4102 (2017).
  Medline CASGoogle Scholar
• 176. Siddiqui MS, Francois M, Hecker J, Faunt J, Fenech MF, Leifert WR. γH2AX is increased in peripheral blood lymphocytes of Alzheimer’s disease patients in the South Australian Neurodegeneration, Nutrition and DNA Damage (SAND) study of aging. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 829–830, 6–18 (2018).
  Medline CASGoogle Scholar
• 177. Clapier CR, Iwasa J, Cairns BR. Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes. Nat. Rev. Mol. Cell Biol. 18(7), 407–422 (2017).
  Medline CASGoogle Scholar
• 178. Mayes K, Qiu Z, Alhazmi A, Landry JW. ATP-dependent chromatin remodeling complexes as novel targets for cancer therapy. Adv. Cancer Res. 121, 183–233 (2014).
  MedlineGoogle Scholar
• 179. Dechassa ML, Sabri A, Pondugula S et al. SWI/SNF has intrinsic nucleosome disassembly activity that is dependent on adjacent nucleosomes. Mol. Cell 38, 590–602 (2010).
  Medline CASGoogle Scholar
• 180. Clapier CR, Kasten MM, Parnell TJ et al. Regulation of DNA translocation efficiency within the chromatin remodeler RSC/Sth1 potentiates nucleosome sliding and ejection. Mol. Cell 62, 453–461 (2016).
  Medline CASGoogle Scholar
• 181. Papamichos-Chronakis M, Watanabe S, Rando OJ, Peterson CL. Global regulation of H2A.Z localization by the INO80 chromatin-remodeling enzyme is essential for genome integrity. Cell 144, 200–213 (2011).
  Medline CASGoogle Scholar
• 182. Brahma S, Udugama MI, Kim J et al. INO80 exchanges H2A.Z for H2A by translocating on DNA proximal to histone dimers. Nat. Commun. 8, 15616 (2017).
  Medline CASGoogle Scholar
• 183. Eustermann S, Schall K, Kostrewa D et al. Structural basis for ATP-dependent chromatin remodelling by the INO80 complex. Nature 556, 386–390 (2018).
  Medline CASGoogle Scholar
• 184. Hasan N, Ahuja N. The emerging roles of ATP-dependent chromatin remodeling complexes in pancreatic cancer. Cancers (Basel) 11(12), 1859 (2019).
  Medline CASGoogle Scholar
• 185. Quan J, Yusufzai T. The tumor suppressor chromodomain helicase DNA-binding protein 5 (CHD5) remodels nucleosomes by unwrapping. J. Biol. Chem. 289, 20717–201726 (2014).
  Medline CASGoogle Scholar
• 186. Zhang H, Wang Y, Cao C et al. A regulatory circuit involving miR-143 and DNMT3a mediates vascular smooth muscle cell proliferation induced by homocysteine. Mol. Med. Rep. 13(1), 483–490 (2016).
  Medline CASGoogle Scholar
• 187. Zhang M, Li F, Wang X et al. MiR-145 alleviates Hcy-induced VSMC proliferation, migration, and phenotypic switch through repression of the PI3K/Akt/mTOR pathway. Histochem. Cell Biol. 153(5), 357–366 (2020).
  Medline CASGoogle Scholar
• 188. Li Y, Chen F, Guo R, Jia S, Li W, Zhang B. Tanshinone IIA inhibits homocysteine-induced proliferation of vascular smooth muscle cells via miR-145/CD40 signaling. Biochem. Biophys. Res. Commun. 522(1), 157–163 (2020).
  Medline CASGoogle Scholar
• 189. Liu K, Xuekelati S, Zhang Y et al. Expression levels of atherosclerosis-associated miR-143 and miR-145 in the plasma of patients with hyperhomocysteinaemia. BMC Cardiovasc. Disord. 17(1), 163 (2017).
  MedlineGoogle Scholar
• 190. Yan P, Sun C, Ma J, Jin Z, Guo R, Yang B. MicroRNA-128 confers protection against cardiac microvascular endothelial cell injury in coronary heart disease via negative regulation of IRS1. J. Cell. Physiol. 234(8), 13452–13463 (2019).
  Medline CASGoogle Scholar
• 191. Griñán R, Escolà-Gil JC, Julve J, Benítez S, Rotllan N. Epigenetic regulation by microRNAs in hyperhomocysteinemia-accelerated atherosclerosis. Int. J. Mol. Sci. 23(20), 12452 (2022).
  Medline CASGoogle Scholar
• 192. Xie L, Ma S, Ding N et al. Homocysteine induces podocyte apoptosis by regulating miR-1929-5p expression through c-Myc, DNMT1 and EZH2. Mol. Oncol. 15(11), 3203–3221 (2021).
  Medline CASGoogle Scholar
• 193. Jie Y, Ding N, Xie L et al. [Homocysteine induces glomerular podocyte apoptosis via up-regulation of miR-488-3p expression in MPC-5 mice]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 38(9), 801–806 (2022).
  MedlineGoogle Scholar
• 194. Li H, Liu M, Yang W et al. Naringenin induces neuroprotection against homocysteine-induced PC12 cells via the upregulation of superoxide dismutase 1 expression by decreasing miR-224-3p expression. J. Biol. Regul. Homeost. Agents 34(2), 421–433 (2020).
  Medline CASGoogle Scholar
• 195. Veeranki S, Winchester LJ, Tyagi SC. Hyperhomocysteinemia associated skeletal muscle weakness involves mitochondrial dysfunction and epigenetic modifications. Biochim. Biophys. Acta 1852(5), 732–741 (2015).
  Medline CASGoogle Scholar
• 196. Wang R, Han Z, Song G, Cui Y, Xia H, Ma X. Homocysteine-induced neural tube defects in chick embryos via oxidative stress and DNA methylation associated transcriptional down-regulation of miR-124. Toxicol. Res. 10(3), 425–435 (2021).
  Google Scholar
• 197. Arutjunyan AV, Milyutina YP, Shcherbitskaia AD, Kerkeshko GO, Zalozniaia IV. Epigenetic mechanisms involved in the effects of maternal hyperhomocysteinemia on the functional state of placenta and nervous system plasticity in the offspring. Biochemistry 88(4), 435–456 (2023).
  Medline CASGoogle Scholar
• 198. An F, Yin Y, Ju W. Long noncoding RNA DANCR expression and its predictive value in patients with atherosclerosis. Bioengineered 13(3), 6919–6928 (2022).
  Medline CASGoogle Scholar
• 199. Safaei S, Tahmasebi-Birgani M, Bijanzadeh M, Seyedian SM. Increased expression level of long noncoding RNA H19 in plasma of patients with myocardial infarction. Int. J. Mol. Med. 9(2), 122–129 (2020).
  CASGoogle Scholar
• 200. Huang J, Yang J, Li J et al. Association of long noncoding RNA H19 polymorphisms with the susceptibility and clinical features of ischemic stroke in southern Chinese Han population. Metab. Brain Dis. 34(4), 1011–1021 (2019).
  Medline CASGoogle Scholar
• 201. Li J, Luo M, Xie N, Wang H, Wang J. Bioinformatics-based analysis of the involvement of AC005550.3, RP11-415D17.3, and RP1-140K8.5 in homocysteine-induced vascular endothelial injury. Am. J. Transl. Res. 10(7), 2126–2136 (2018).
  Medline CASGoogle Scholar
• 202. Li W, Li Y, Cui S et al. Se alleviates homocysteine-induced fibrosis in cardiac fibroblasts via downregulation of lncRNA MEG3. Exp. Ther. Med. 22(5), 1269 (2021).
  Medline CASGoogle Scholar
• 203. Diao L, Bai L, Jiang X, Li J, Zhang Q. Long-chain noncoding RNA GAS5 mediates oxidative stress in cardiac microvascular endothelial cells injury. J. Cell. Physiol. 234(10), 17649–17662 (2019).
  Medline CASGoogle Scholar
• 204. Gu L, Xu L, Yang A, Jiao Y, Zhang H, Jiang Y. [Long non-coding RNA growth arrest specific transcript 5 (lncGAS5) promotes autophagy of hepatocytes induced by homocysteine]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 37(3), 240–245 (2021).
  MedlineGoogle Scholar
• 205. Zheng M, Zheng Y, Gao M et al. Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients. Exp. Ther. Med. 19(2), 1329–1335 (2020).
  Medline CASGoogle Scholar
• 206. Ding S, Zhu Y, Liang Y. Circular RNAs in vascular functions and diseases. Adv. Exp. Med. Biol. 1087, 287–297 (2018).
  Medline CASGoogle Scholar
• 207. Singh M, George AK, Homme RP et al. Circular RNAs profiling in the cystathionine-β-synthase mutant mouse reveals novel gene targets for hyperhomocysteinemia induced ocular disorders. Exp. Eye Res. 174, 80–92 (2018).
  Medline CASGoogle Scholar
• 208. Singh M, George AK, Homme RP et al. Expression analysis of the circular RNA molecules in the human retinal cells treated with homocysteine. Curr. Eye Res. 44(3), 287–293 (2019).
  Medline CASGoogle Scholar
• 209. Eyob W, George AK, Homme RP et al. Regulation of the parental gene GRM4 by circGrm4 RNA transcript and glutamate-mediated neurovascular toxicity in eyes. Mol. Cell. Biochem. 476(2), 663–673 (2021).
  Medline CASGoogle Scholar
• 210. Hu F, Sha W, Dai H et al. Lower expression of Hsa_circRNA_102682 in diabetic hyperhomocysteinemia negatively related to creatinemia is associated with TGF-β and CTGF. J. Clin. Lab. Anal. 35(8), e23860 (2021).
  Medline CASGoogle Scholar
• 211. Gao L, Wu Q, Yin H et al. [The nuclear translocation of circRNA CPSF6 promotes apoptosis of trophoblast cells induced by homocysteine]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 38(2), 146–152 (2022).
  MedlineGoogle Scholar
• 212. Sharma GS, Singh LR. Conformational status of cytochrome C upon N-homocysteinylation: implications to cytochrome C release. Arch. Biochem. Biophys. 614, 23–27 (2017).
  Medline CASGoogle Scholar
• 213. Gurda D, Handschuh L, Kotkowiak W, Jakubowski H. Homocysteine thiolactone and N-homocysteinylated protein induce pro-atherogenic changes in gene expression in human vascular endothelial cells. Amino Acids 47(7), 1319–1339 (2015).
  Medline CASGoogle Scholar
• 214. Moshtaghie E, Nayeri H, Moshtaghie AA, Asgary S. The effect of homocysteine thiolactone on paraoxonase and aryl esterase activity of human serum purified paraoxonase 1 in vitro experiments. ARYA Atheroscler. 18(2), 1–6 (2022).
  MedlineGoogle Scholar
• 215. Genoud V, Quintana PG, Gionco S, Baldessari A, Quintana I. Structural changes of fibrinogen molecule mediated by the N-homocysteinylation reaction. J. Thromb. Thrombolysis 45(1), 66–76 (2018).
  Medline CASGoogle Scholar
• 216. Xu L, Chen J, Gao J, Yu H, Yang P. Crosstalk of homocysteinylation, methylation and acetylation on histone H3. Analyst 140(9), 3057–3063 (2015).
  Medline CASGoogle Scholar
• 217. AnandBabu K, Sen P, Angayarkanni N. Oxidized LDL, homocysteine, homocysteine thiolactone and advanced glycation end products act as pro-oxidant metabolites inducing cytokine release, macrophage infiltration and pro-angiogenic effect in ARPE-19 cells. PLoS ONE 14(5), e0216899 (2019).
  Medline CASGoogle Scholar
• 218. Jakubowski H. Homocysteine modification in protein structure/function and human disease. Physiol. Rev. 99(1), 555–604 (2019).
  Medline CASGoogle Scholar
• 219. Jakubowsk H, Boers GH, Strauss KA. Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans. FASEB J. 22(12), 4071–4076 (2008).
  MedlineGoogle Scholar
• 220. Kameda T, Horiuchi Y, Shimano S et al. Effect of myeloperoxidase oxidation and N-homocysteinylation of high-density lipoprotein on endothelial repair function. J. Biol. Chem. 403(3), 265–277 (2021).
  Google Scholar
• 221. Bossenmeyer-Pourié C, Smith AD, Lehmann S et al. N-homocysteinylation of tau and MAP1 is increased in autopsy specimens of Alzheimer’s disease and vascular dementia. J. Pathol. 248(3), 291–303 (2019).
  Medline CASGoogle Scholar
• 222. Jakubowski H. Homocysteine modification in protein structure/function and human disease. Physiol. Rev. 99(1), 555–604 (2019).
  Medline CASGoogle Scholar
• 223. Zhang Q, Bai B, Mei X et al. Elevated H3K79 homocysteinylation causes abnormal gene expression during neural development and subsequent neural tube defects. Nat. Commun. 9(1), 3436 (2018).
  MedlineGoogle Scholar
• 224. Gu Y, Zhang Q, Guo J et al. Higher serum homocysteine and lower thyroid hormone levels in pregnant women are associated with neural tube defects. J. Trace Elem. Med. Biol. 68, 126814 (2021).
  Medline CASGoogle Scholar
• 225. Yu Y, Jia C, Shi Q, Zhu Y, Liu Y. Hyperhomocysteinemia in men with a reproductive history of fetal neural tube defects: three case reports and literature review. Medicine (Baltimore) 98(2), e13998 (2019).
  MedlineGoogle Scholar
• 226. Genoud V, Quintana PG, Gionco S, Baldessari A, Quintana I. Structural changes of fibrinogen molecule mediated by the N-homocysteinylation reaction. J. Thromb. Thrombolysis 45(1), 66–76 (2018).
  Medline CASGoogle Scholar
• 227. Ma S, Zhang H, Jiao Y et al. Homocysteine-induced proliferation of vascular smooth muscle cells occurs via PTEN hypermethylation and is mitigated by Resveratrol. Mol. Med. Rep. 17(4), 5312–5319 (2018).
  Medline CASGoogle Scholar
• 228. Carrizzo A, Iside C, Nebbioso A et al. SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency. Cell. Mol. Life Sci. 79(8), 410 (2022).
  Medline CASGoogle Scholar
• 229. Xiang Y, Liang B, Zhang X et al. Atheroprotective mechanism by which folic acid regulates monocyte subsets and function through DNA methylation. Clin. Epigenetics 14(1), 32 (2022).
  Medline CASGoogle Scholar
• 230. Pizzolo F, Blom HJ, Choi SW et al. Folic acid effects on s-adenosylmethionine, s-adenosylhomocysteine, and DNA methylation in patients with intermediate hyperhomocysteinemia. Am. J. Coll. Nutr. 30(1), 11–18 (2011).
  Medline CASGoogle Scholar
• 231. Zhou S, Zhang Z, Xu G. Notable epigenetic role of hyperhomocysteinemia in atherogenesis. Lipids Health Dis. 13, 134 (2014).
  Medline CASGoogle Scholar
• 232. Rysz J, Franczyk B, Rysz-Górzyńska M, Gluba-Brzózka A. Are alterations in DNA methylation related to CKD development? Int. J. Mol. Sci. 23(13), 7108 (2022).
  Medline CASGoogle Scholar
• 233. Capelli I, Cianciolo G, Gasperoni L et al. Folic acid and vitamin B12 administration in CKD, why not? Nutrients 11(2), 383 (2019).
  Medline CASGoogle Scholar